Mr. Cutler joined Synthetic Genomics as General Counsel in 2016. Prior to joining Synthetic Genomics, Rob was General Counsel and Corporate Secretary at LifeVantage Corporation from 2011 to 2015 where he was responsible for all legal, regulatory, and compliance activities, managed all securities filings, and led expansion into multiple foreign jurisdictions. Rob also served as Associate General Counsel and Senior Director of Business Development at Biogen Idec Inc. from 2001 to 2010 where he managed business development efforts for the oncology business unit and closed over $1.5 billion in transactions including acquisitions, multi-product collaborations, strategic alliances, product divestitures, and research and academic collaborations. Prior to joining Biogen Idec, Rob spent several years in private law practice with two large full service law firms where he counseled both private and public companies in securities matters, general corporate transactions and mergers and acquisitions.
Rob received his Juris Doctor (JD) degree, graduating cum laude from the Brigham Young University J. Reuben Clark Law School.